Edition:
United Kingdom

Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

3.03USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$3.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,183
52-wk High
$4.75
52-wk Low
$2.60

Latest Key Developments (Source: Significant Developments)

Evogene Q3 loss per share $0.20
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Evogene Ltd ::Evogene reports third quarter 2017 financial results.Q3 revenue $700,000 versus $1.5 million.Evogene Ltd - ‍in 2018, Evogene expects net cash usage of $14 million to $16 million.Evogene Ltd qtrly loss per share $0.20​.  Full Article

BRIEF-Evogene And Marrone Bio Innovations Announce Phase Advancement In Their Insect Control Collaboration

* EVOGENE AND MARRONE BIO INNOVATIONS ANNOUNCE PHASE ADVANCEMENT IN THEIR INSECT CONTROL COLLABORATION

No consensus analysis data available.